Drugs / Onexton
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | ACANYA | — | 2008-10-23 | fda.gov ↗ |
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03402893 | Jul → Nov 2017 | acne, hyperpigmentation of the skin | Derm Research, PLLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Onexton | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03402893 ↗ |
| Route | Topical | “Onexton gel applied once daily to face” NCT03402893 ↗ |